Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7438756
Reference Type
Journal Article
Title
Amenorrhea and Estrogen Disorders in Women with Kidney Disease
Author(s)
Vellanki, K; Kramer, H; ,
Year
2019
Publisher
Springer International Publishing
Location
Cham
Book Title
Endocrine Disorders in Kidney Disease
Page Numbers
127-138
DOI
10.1007/978-3-319-97765-2_10
URL
http://link.springer.com/10.1007/978-3-319-97765-2_10
Exit
Abstract
Endocrine abnormalities from altered synthesis and metabolism of sex hormones are a common feature in both men and women with chronic kidney disease (CKD). Despite the fact that kidney disease affects approximately one out of ten women in the United States and one out of five women over the age of 60 years, women’s health issues in the setting of CKD remain one of the most neglected and under-recognized issues in clinical practice. While the exact mechanisms are unclear, impairment in the hypothalamic-pituitary axis due to uremia, underlying comorbid conditions, and concomitant medication use are thought to play a predominant role. Abnormal menstrual cycles with amenorrhea, often associated with anovulation, are common in premenopausal women with kidney disease. Early menopause is also common in CKD with the potential negative effects of early menopause on cardiovascular and bone health poorly determined. Diagnosis and management of menopausal symptoms and postmenopausal osteoporosis in CKD remain challenging and controversial. Sexual dysfunction is highly prevalent in women on dialysis, but these symptoms improve markedly post-kidney transplant. While infertility is common, restoration of fertility in women with moderate to severe non-dialysis-dependent CKD should be discouraged due to risk of CKD progression.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity